Abbott Reports Double-Digit Sales and Ongoing Earnings Growth in Fourth Quarter
- Details
- Category: Abbott
![Abbott Abbott](/images/stories/logo/abbott.gif)
Pediatric Exclusivity For PLAVIX®
- Details
- Category: Bristol-Myers Squibb
![Bristol-Myers Squibb Bristol-Myers Squibb](/images/stories/logo/bms.gif)
GlaxoSmithKline announces start of two phase III studies in advanced/metastatic melanoma
- Details
- Category: GlaxoSmithKline
![GlaxoSmithKline GlaxoSmithKline](/images/stories/logo/gsk.gif)
AstraZeneca Replies to FDA Complete Response Letter for BRILINTA
- Details
- Category: AstraZeneca
![AstraZeneca AstraZeneca](/images/stories/logo/astrazeneca.gif)
Genzyme to Build Additional Plant to Support Growth of Myozyme® and Lumizyme®
- Details
- Category: Genzyme
![Genzyme Genzyme](/images/stories/logo/genzyme.gif)
The clinical phase III programme commenced on zicronapine
- Details
- Category: Lundbeck
![Lundbeck Lundbeck](/images/stories/logo/lundbeck.gif)
Roche personalized investigational medicine shows survival benefit in advanced skin cancer
- Details
- Category: Roche
![Roche Roche](/images/stories/logo/roche.gif)
More Pharma News ...
- Bayer and Regeneron start MYRROR Phase III Trial
- Boehringer Ingelheim to Purchase Amgen's Fremont (California) Facility
- GlaxoSmithKline announces Q4 2010 legal charge
- European Commission Clears Acquisition of Genzyme Corporation by sanofi-aventis
- Boehringer Ingelheim and Eli Lilly and Company Announce Strategic Alliance
- Sandoz announces phase II clinical trial for biosimilar version of rituximab
- GlaxoSmithKline and ChemoCentryx announce initiation of Phase III study of GSK'786